CEntralized Pan-Russian Survey of tHE Undertreatment of hypercholeSterolemia II (CEPHEUS II)

CompletedOBSERVATIONAL
Enrollment

2,700

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Dyslipidaemia
Trial Locations (27)

Unknown

Research Site, Belgorod

Research Site, Berdsk

Research Site, Domodedovo

Research Site, Engel's

Research Site, Ivanovo

Research Site, Kaluga

Research Site, Kirovsk

Research Site, Korolyov

Research Site, Krasnodar

Research Site, Krasnoyarsk

Research Site, Moscow

Research Site, Mytishchy

Research Site, Nizhny Novgorod

Research Site, Novosibirsk

Research Site, Odintsovo

Research Site, Orenburg

Research Site, Penza

Research Site, Pushkino

Research Site, Rostov-on-Don

Research Site, Saint Petersburg

Research Site, Samara

Research Site, Sergiyev Posad

Research Site, Sochi

Research Site, Volgograd

Research Site, Voronezh

Research Site, Yaroslavl

Research Site, Yekaterinburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY